{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:06:28Z","timestamp":1791227188565,"version":"4.1.0"},"reference-count":40,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T00:00:00Z","timestamp":1470700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T00:00:00Z","timestamp":1473206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["085440\/Z\/08\/Z"],"award-info":[{"award-number":["085440\/Z\/08\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["mBio"],"published-print":{"date-parts":[[2016,9,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Each year, millions of African children receive praziquantel (PZQ) by mass drug administration (MDA) to treat schistosomiasis at a standard single dose of 40\u00a0mg\/kg of body weight, a direct extrapolation from studies of adults. A higher dose of 60\u00a0mg\/kg is also acceptable for refractory cases. We conducted the first PZQ pharmacokinetic (PK) and pharmacodynamic (PD) study in young children comparing dosing. Sixty Ugandan children aged 3 to 8 years old with egg patent\n                    <jats:named-content content-type=\"genus-species\">Schistosoma mansoni<\/jats:named-content>\n                    received PZQ at either 40\u00a0mg\/kg or 60\u00a0mg\/kg. PK parameters of PZQ racemate and enantiomers (\n                    <jats:italic>R<\/jats:italic>\n                    and\n                    <jats:italic>S<\/jats:italic>\n                    ) were quantified. PD outcomes were assessed by standard fecal egg counts and novel schistosome-specific serum (circulating anodic antigen [CAA]) and urine (circulating cathodic antigen [CCA]) antigen assays. Population PK and PD analyses were performed to estimate drug exposure in individual children, and the relationship between drug exposure and parasitological cure was estimated using logistic regression. Monte Carlo simulations were performed to identify better, future dosing regimens. There was marked PK variability between children, but the area under the concentration-time curve (AUC) of PZQ was strongly predictive of the parasitological cure rate (CR). Although no child achieved antigenic cure, which is suggestive of an important residual adult worm burden, higher AUC was associated with greater CAA antigenic decline at 24\u00a0days. To optimize the performance of PZQ, analysis of our simulations suggest that higher doses (&gt;60\u00a0mg\/kg) are needed, particularly in smaller children.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>IMPORTANCE<\/jats:bold>\n                    Schistosomiasis is a neglected tropical disease, typically associated with chronic morbidity, and its control is a global health priority. Praziquantel (PZQ) is the only available antiparasitic drug and is often given out, as a single oral dose (40\u00a0mg\/kg), to school-aged children by mass drug administration (MDA) schemes operating within preventive chemotherapy campaigns as endorsed by the World Health Organization (WHO). This current strategy has several limitations. (i) It excludes preschool children who can be patently infected. (ii) It delivers PZQ at a dose directly extrapolated from adult pharmacological studies. To address these problems, we conducted the first pharmacokinetic and pharmacodynamic study of young children within an area of Uganda where\n                    <jats:named-content content-type=\"genus-species\">Schistosoma mansoni<\/jats:named-content>\n                    is hyperendemic. Our results demonstrate that a higher dose (&gt;60\u00a0mg\/kg) is required, especially in smaller children, and draw attention to the need for further optimization of PZQ treatment based on schistosome antigenic assays, which are more sensitive to pharmacodynamic markers.\n                  <\/jats:p>","DOI":"10.1128\/mbio.00227-16","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T21:43:11Z","timestamp":1470778991000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":69,"title":["Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy"],"prefix":"10.1128","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6131-4159","authenticated-orcid":false,"given":"Amaya L.","family":"Bustinduy","sequence":"first","affiliation":[{"name":"Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"},{"name":"Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Waterhouse","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose C.","family":"de Sousa-Figueiredo","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Angola, Hospital Provincial, Caxito, Bengo, Angola"},{"name":"Department of Life Sciences, Natural History Museum, Wolfson Wellcome Biomedical Laboratories, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Center for Biostatistics, Manchester Academic Health Sciences Centre (MAHSC), University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Atuhaire","sequence":"additional","affiliation":[{"name":"Vector Control Division, Ministry of Health, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govert J.","family":"Van Dam","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L. A. M.","family":"Corstjens","sequence":"additional","affiliation":[{"name":"Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet T.","family":"Scott","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C.","family":"Stanton","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narcis B.","family":"Kabatereine","sequence":"additional","affiliation":[{"name":"Vector Control Division, Ministry of Health, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Ward","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Hope","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Russell","family":"Stothard","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328318978f"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61949-2"},{"key":"e_1_3_2_4_2","volume-title":"Assessing the efficacy of anthelmintic drug against schistosomiasis and soil-transmitted helminthiases","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. 2013. Assessing the efficacy of anthelmintic drug against schistosomiasis and soil-transmitted helminthiases. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(90)90333-A"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt491"},{"key":"e_1_3_2_7_2","volume-title":"Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers","author":"World Health Organization","year":"2006","unstructured":"World Health Organization. 2006. Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00389899"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4049\/jimmunol.139.1.215","article-title":"The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response","volume":"139","author":"Brindley PJ","year":"1987","unstructured":"Brindley PJ, Sher A. 1987. The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. J Immunol 139:215\u2013220.","journal-title":"J Immunol"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002109"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2013.06.017"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001143"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/1043-6618(95)80048-4"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1989.41.204"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1989.41.198"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02741-14"},{"key":"e_1_3_2_17_2","first-page":"593","article-title":"Levo-praziquantel versus praziquantel in experimental and clinical treatment of schistosomiasis japonica","volume":"106","author":"Liu YH","year":"1993","unstructured":"Liu YH, Qian MX, Wang XG, Quan YZ, Yan SH, Chen BY, Li JS, Qiu ZY. 1993. Levo-praziquantel versus praziquantel in experimental and clinical treatment of schistosomiasis japonica. Chin Med J 106:593\u2013596.","journal-title":"Chin Med J"},{"key":"e_1_3_2_18_2","first-page":"935","article-title":"Comparative efficacy of praziquantel and its optic isomers in experimental therapy of schistosomiasis japonica in rabbits","volume":"99","author":"Liu YH","year":"1986","unstructured":"Liu YH, Qian MX, Wang XG, Jia J, Wang QN, Jiang YF, Wang RQ, Yan SH, Chen BY, Li JS. 1986. Comparative efficacy of praziquantel and its optic isomers in experimental therapy of schistosomiasis japonica in rabbits. Chinese Med J 99:935\u2013940.","journal-title":"Chinese Med J"},{"key":"e_1_3_2_19_2","first-page":"732","article-title":"Comparative efficacy of levo-praziquantel and praziquantel in treatment of schistosomiasis japonica at a single dose","volume":"104","author":"Wu MH","year":"1991","unstructured":"Wu MH, Wei CC, Xu ZY, Yuan HC, Lian WN, Yang QJ, Chen M, Wang CZ, Zhang ZJ, Liu ZD. 1991. Comparative efficacy of levo-praziquantel and praziquantel in treatment of schistosomiasis japonica at a single dose. Chin Med J 104:732\u2013735.","journal-title":"Chin Med J"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645110-00003"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1994.51.809"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/1756-3305-7-153"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1179\/136485906X105552"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2004.01282.x"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001864"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00560463"},{"key":"e_1_3_2_27_2","volume-title":"Report of a meeting to review the results of studies on the treatment of schistosomiasis in preschool-age children","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. 2011. Report of a meeting to review the results of studies on the treatment of schistosomiasis in preschool-age children. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/159.3.589"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1991.45.345"},{"key":"e_1_3_2_30_2","first-page":"381","article-title":"Biotransformation of praziquantel by human cytochrome P450 3A4 (CYP 3A4)","volume":"63","author":"Godawska-Matysik A","year":"2006","unstructured":"Godawska-Matysik A, Kie\u0107-Kononowicz K. 2006. Biotransformation of praziquantel by human cytochrome P450 3A4 (CYP 3A4). Acta Pol Pharm 63:381\u2013385.","journal-title":"Acta Pol Pharm"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.054841"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00927527"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000528.pub2"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000053.pub2"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001165"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002008"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.inhe.2010.02.003"},{"key":"e_1_3_2_38_2","first-page":"397","article-title":"A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni","volume":"14","author":"Katz N","year":"1972","unstructured":"Katz N, Chaves A, Pellegrino J. 1972. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14:397\u2013400.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.10.2404-2406.1994"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2009.07.036"},{"key":"e_1_3_2_41_2","volume-title":"ADAPT 5 user\u2019s guide: pharmacokinetic\/pharmacodynamic systems analysis software","author":"D\u2019Argenio DZ","year":"2009","unstructured":"D\u2019Argenio DZ, Schumitzky A, Wang X. 2009. ADAPT 5 user\u2019s guide: pharmacokinetic\/pharmacodynamic systems analysis software. Biomedical Simulations Resource, Los Angeles, CA."}],"container-title":["mBio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mBio.00227-16","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mBio.00227-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:39:00Z","timestamp":1749040740000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/mBio.00227-16"}},"subtitle":[],"editor":[{"given":"Michael Noel","family":"Neely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"George L.","family":"Drusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,9,7]]}},"alternative-id":["10.1128\/mBio.00227-16"],"URL":"https:\/\/doi.org\/10.1128\/mbio.00227-16","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726629917.793522309","asserted-by":"object"}]},"ISSN":["2161-2129","2150-7511"],"issn-type":[{"value":"2161-2129","type":"print"},{"value":"2150-7511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,7]]},"assertion":[{"value":"2016-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-08-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00227-16"}}